Hemagen Diagnostics, Inc. (HMGN)
Makes diagnostic test kits for detecting autoimmune and infectious diseases in humans and animals.
$0.00+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago+100.0%
The outlook
HMGN is trading near its 52-week lows with minimal daily movement. The stock sits well below both its 50-day and 200-day moving averages, reflecting a sustained downtrend. Data suggests weak analyst coverage and a bearish sentiment backdrop.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$3,100
52-wk high
$0.13
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—